The content on the Upper payment limit archive page is archived to conform with the rule on digital accessibility under Americans with Disabilities Act. It meets the following: 1. Created before April 24, 2026, or reproduces the contents of other physical media created before that date. 2. Is retained exclusively for reference, research, or recordkeeping. 3. Is not altered or updated after the date of archiving. 4. Is organized and stored in a dedicated area or areas clearly identified as being archived.
In 2023, the Oregon Legislature expanded the board’s mission through Senate Bill 192 to “develop a plan for establishing upper payment limits on drugs sold in this state that are subject to affordability reviews under ORS 646A.694.” The Prescription Drug Affordability Board worked with consultants Myers and Stauffer LC on an upper payment limit report. Consultants held 23 community meetings and focus groups April through July, 2024, and the board hosted question and answer sessions on July 24. The board reviewed and discussed the draft UPL report in October and November, voting for approval on Nov. 20, 2024 to send to the Oregon Legislature.
UPL Final Report
UPL Public Comments
UPL Draft Report
Constituent Group Engagement Report
Consumer Outreach Report
Constituent meeting materials
Documents submitted by constituents
Board question and answer session with constituents (July 24 board meeting)
Constituent meeting video recordings:
|
Constituent Group |
Session 1 |
Session 2 |
|---|
|
Community Forums |
May 8, 2024 |
May 14, 2024 |
|
Non-Grocery Pharmacy |
May 16, 2024 |
June 12, 2024 |
|
Grocery Store Pharmacy |
5/29/2024 no recording available |
June 5, 2024 |
|
Insurers/Carriers |
May 16, 2024 |
May 29, 2024 |
|
Hospitals |
May 20, 2024 |
May 30, 2024 |
|
340B |
May 22, 2024 |
May 30, 2024 |
|
PBM |
July 2, 2024 no recording available |
July 16, 2024 |
|
Patient Advocacy |
July 1, 2024 |
July 11, 2024 |
|
Manufacturers |
July 1, 2024
|
July 10, 2024 |